Antimicrobial Susceptibilities of Group B Streptococci Isolated from Patients with Invasive Disease: 10-Year Perspective

Antimicrobial susceptibility testing of 192 group B streptococcal isolates from patients with invasive disease demonstrated that 31 (16%) were resistant to erythromycin and 17 (9%) were resistant to clindamycin. One isolate demonstrated high-level resistance to streptomycin, but none was highly resi...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Murdoch, David R., Reller, L. Barth
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90883/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11709354/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.12.3623-3624.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!